EBB Invest, a Swedish pharmaceutical company, was established in southern Sweden in 2011. It consists of four subsidiaries based in Sweden and Lithuania.
EBB operates in a particularly competitive industry, which requires that it stays on top of new trends and ways to improve its ways of working. It describes itself as dynamic and flexible. To stay ahead of the changing times and competition, efficiency is absolute key.
